Intended for healthcare professionals

Editor's Choice

A tough nut to crack

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7485.0-h (Published 27 January 2005) Cite this as: BMJ 2005;330:0-h
  1. Kamran Abbasi, acting editor (kabbasi@bmj.com)

“The drug industry considers the BMJ a tough nut to crack,” an insider recently told us. Publishing a “favourable” research paper is far trickier in the BMJ than other journals, he said, but when a paper is published it's worth £200m to the company. Some of that revenue inevitably finds its way into the “swimming pool” funds of highly paid doctors who trot the globe's conference venues putting a positive spin on company products. “You're just anti-industry,” complains one of our marketing team, pointing an accusing finger at the BMJ's editors. We're not anti-industry, of course, …

View Full Text